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F i g u r e 1 . S c h e m a t i c r e p r e s e n t a t i o n o f B l a g 4 f r a g me n t s for the eiptope analysis 16 
(T to A), 110 (E to D), 131 (I to L), 133 (F to L), 134 (S to T), and 135 (V to W). Of note, the
amino acid residues at 51-75 and 132-155 showed a high degree of sequence variation. These data suggest that Bla g 4 is highly polymorphic. A multiple amino acid sequence alignment with eight allergenic lipocalin family proteins was carried out by using the Clustal X program.
Despite the probable structural similarity, the identity between the sequences was very low,
showing only the two identical residues, Gly33 and Trp35 to the main conserved segment of the lipocalin family. Their influence on IgE-binding capacity and T cell responsiveness will be investigated in order to better understand immune responses to Bla g 4. were generated by PCR and over-expressed in E. coli BL21 (DE3). The IgE binding reactivities of the full-length and peptide fragments were measured by enzyme linked immunosorbent assay (ELISA) using 32 serum samples of from patients with cockroach allergies. The sera of 8 patients (25%) reacted with rBla g 4, a prevalence significantly lower than the 40~60% reported previously by Arruda et al (1996) . Four sera (100%) showed IgE-binding reactivity to fulllength and peptide fragment 4, 3 sera (80%) reacted with peptide fragment 2, one (20%) serum
Ι. INTRODUCTION
The treatment of allergic diseases in the past was largely dependent on medication. 1 However, the knowledge of the protein chemistry of allergens has improved during the past 20 years.
Allergen standardization is no longer based on protein nitrogen units or weight/volume estimates. Biological and immunochemical procedures have been introduced by regulatory authorities in the United States and Europe to improve standardization of natural allergenic products. 2, 3 However, allergens prepared from natural source materials remain heterogeneous products, containing many non-allergenic proteins and other macromolecules that are parenterally administered together with the few active components, the protein allergens.
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Natural allergenic products are also at risk of being contaminated with allergens from other sources and can contain proteolytic enzymes. 4 These enzyme may be either allergenic or nonallergenic and can decrease the stability of specific allergens when treated together with other allergens during immunotherapy. 5 Occasionally, standardized allergen vaccines contain endotoxins, 6, 7 which can cause unpredictable effects such as enhanced T H 1 responses or toxic and inflammatory responses. 8 It is difficult to standardize a specific allergen in a mixture of different proteins. These limitations can improve on natural allergenic products by use of recombinant allergens. 9 The use of recombinant allergens in structural and immunologic studies requires the production of large quantities of allergen that can be easily purified from suitable expression vectors. Recombinant allergens for immunotherapy may be used to alter immune responses or to reduce the allergenic activity of other allergens. Genetically modified recombinant allergens provide several advantages. These molecules preserve the repertoire of allergen-specific T cell epitopes and inhibit the binding of allergic patients' IgE antibodies to allergens represented by B cell epitopes. 10 Specially, hypoallergens with reduced allergenic activity could be obtained by site-directed mutagenesis of IgE binding epitopes. These studies are useful for the designing of specific immunotherapy.
Cockroaches are insects of the Order Blattodea. The name of the order is derived from the Greek word for "cockroach," blatta. There are roughly 3,500 species in six families.
Cockroaches exist worldwide, except in polar regions. The most commonly found domestic 6 6 6 species of cockroach are Blattella germanica (German cockroach) and Periplaneta Americana (American cockroach). In Korea, cockroaches were found in 62% (107/174) of homes, i.e., 63
with B. germanica, 60 with Periplaneta spp., which included 16 homes infested with both.
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Exposure to high levels of cockroach allergens is an important factor for the production of IgE antibodies and development of allergic disease. Cockroaches have been reported to be associated with asthma in many regions of the world, including Taiwan, Japan, Thailand, and
Singapore in the Pacific Rim; Costa Rica and Puerto Rico in Central America; India; South Africa; and parts of Europe. 12 These problems were caused by high levels of cockroach allergens in low-cost public housing, 13 which were associated with positive allergy skin test responses in a group of children with mild-to-moderate asthma. 14 Recently, among urban asthmatic subjects sensitized to cockroach allergens, exposure to high levels of cockroach allergens in the home was strongly associated with increased hospitalizations and other measures of asthma morbidity. 15 Patients with cockroach allergies had especially high levels of serum IgE antibodies compared to general asthmatics. Although the effect of professional extermination and house cleaning resulted in cockroach population decrease and substantial reduction of allergen levels in some homes, the allergen levels in most homes remained high enough to induce asthma symptoms in sensitized individuals. 16 Several German cockroach allergens, which stimulate IgE production and cause IgE-mediated 7 7 7 diseases, have been identified. Six allergens have been cloned and immunologically characterized from B. germanica. These allergens differ in structure and function. Bla g 1 has variable molecular weights, [17] [18] [19] with a primary structure that consists of several tandem repeats of approximately 100 amino acids. The prevalence of IgE binding to purified protein was approximately 77%, 20 but the function of Bla g 1 remains unknown. Bla g 2 is 36 kDa and an inactive aspartic protease, 21 the prevalence of IgE antibodies was from 60% to 68%. 22 Bla g 4
has an estimated molecular weight of 21 kDa and belongs to the lipocalin super-family, which binds or transports small hydrophobic molecules. 23 IgE binding reactivity to recombinant protein was found in 40~60% of cockroach-allergic patients. 24 Bla g 5 has been identified as a 23 KDa glutathione S-transferase (GST). IgE antibodies against Bla g 5 were found in 70% of cockroach-allergic patients. 25 Bla g 6 encodes troponin C, an 18 kDa 26 calcium-binding subunit of troponin that regulates muscle contraction. The prevalence of IgE binding to recombinant protein was 14%. 27 Bla g 7 encoded the 33 KDa tropomyosin, which exhibited a IgE binding reactivity of 16.2% among patients with cockroach allergies. 28 In a recent study, the relative importance of cockroach allergens (Bla g 1, Bla g 2, Bla g 4, Bla g 5, and Bla g 7) was measured by IgE antibodies in over 100 sera from cockroach-sensitized subjects. Thirty-six of the sera did not react any of 5 the allergens, despite having a positive IgE CAP to B.
germanica. 29 This result indicated that these 5 allergens do not represent the full repertoire of German cockroach allergens, suggesting that other allergens exist in B. germanica.
Bla g 4 is a species-specific allergen produced by B. germanica 23 and expressed in a sexspecific manner in the reproductive system of adult male German cockroaches. It is associated with the spermatophore, transferred to the female during copulation and developmentally regulated by juvenile hormone. 30 Although the sequence identity between Bla g 4 and lipocalins is low (19~24%), it contains the three structurally conserved regions (SCR) of lipocalin. different immunoglobulin E binding activities, [32] [33] [34] and amino acid substitutions can render T cell epitopes active or inactive. 35 Also, the cytokine patterns of T cell responses induced by different variants of recombinant Der p 2 were found to differ even with a single amino acid substitution. 32 This demonstrates that the occurrence of even just a few amino acid substitutions could alter the immune responses.
Ⅱ Ⅱ Ⅱ Ⅱ. METERIALS AND METHODS

Patient sera
A total of 47 sera were included in this study. Thirty-two cockroach-allergic patients and fifteen healthy individuals without cockroach allergies were recruited, and their sera were studied.. The allergic patients (n = 32, ages ranging from 7 to 58 years) attended the Allergy clinic of Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. All sera were confirmed for the presence of IgE antibodies > 0.7 kU/L against B. germanica using the Uni-CAP system (Pharmacia, Uppsala, Sweden). Table 1 shows the characteristics of the 32 allergic patients and 15 negative controls.
Molecular cloning of Bla g 4 cDNA
Total RNA was isolated from six adult B. germanica males using the Trizol reagent 
Sequence analysis and database search
A ThermoSequence kit (Amersham Life Science, Cleveland, Ohio) was used for nucleotide sequence determination. Reaction mixtures were run on a Long ReadIR 4200 DNA sequencer (LI-COR Inc., Lincoln, NE, USA). All reactions (both forward and reverse) were performed in duplicate. Sequence alignments and database homology searches, multiple sequence alignments were performed using the BioEdit (www.Mbio.ncsu.edu/BioEdit) and CLUSTAL X programs (ftp://ftp-igbmc.u-strasbg.fr/pub/ClustalX). Comparison of amino acid sequences was carried 12 out at the NCBI site using the BLAST network service. The predominant form was submitted to the GenBank database, under the accession number EF202172.
Expression and construction of Bla g 4 peptide fragments
To express the recombinant Bla g 4 in E. coli, the full-length Bla g 4 cDNA was amplified from pGEM-T Easy-Bla g 4. Bla g 4 (EF202172) was divided into five overlapping peptide fragments (E1~E5; E1: aa 1-100, E2: aa 34-77, E3: aa 74-117, E4: aa 114-156, and E5: aa 153-182) (Fig. 1) . The specific primers used in PCR are listed in Table 2 
IgE binding reactivity and IgE epitope analysis of recombinant Bla g 4
Purified recombinant Bla g 4 was diluted to 10 ㎍/mL in a coating buffer (0.1 M sodium carbonate, pH 9.6). Each well of a 96-well microplate was coated with 100 μl of the recombinant protein and incubated at 4°C overnight, followed by washing with phosphate- IgE binding reactivities of the peptide fragments were measured by enzyme-linked immunosorbent assay (ELISA) using four sera samples obtained from recombinant Bla g 4 positive patients. Purified recombinant peptide fragments (10㎍/mL) in a coating buffer (0.1 M sodium carbonate, pH 9.6) were coated into each well of the microplate and the ELISA was performed as described above. The cut-off value was the absorbance level plus two standard deviations of four healthy controls. Each determination was done in duplicate. Table 2 . Sequences of oligonucleotides used for the production of fragments of Bla g 4
The underlined bases denote the restriction enzyme site.
Ⅲ Ⅲ Ⅲ Ⅲ. RESULTS
Sequence analysis of Bla g 4 cDNA
The full-length of Bla g 4 cDNA clone was obtained by RT-PCR using the specific primers based on the previously reported sequence (GenBank accession number U40767). The complete sequence was 548 nucleotides ( The evolutionary relationships between the variants are shown in Fig.3 , and were further analyzed using phylogenetic tree analysis. These analyses showed that the variants belonged 18 18 18 to five groups. 
Homology of allergenic lipocalins
A multiple amino acid sequence alignment with eight allergenic lipocalin family proteins was carried out by using the Clustal X program (Fig. 5) . Despite the identity between the sequences being very low, the similarity of the overall structures was expected to be very high. The two identical residues, Gly33 and Trp35 (Bla g 4 numbering) in the main conserved segment of the lipocalin family are shown. 
Expression of recombinant Bla g 4 and peptide fragments
Full-length and peptide fragments containing BamHⅠ-XhoΙ were subcloned into the pET-28b expression vector. The recombinant proteins were expressed as N-terminal fusion proteins with six histidine residues. The full-length and fragments 1, 2, and 4 were obtained from an insoluble fraction, while fragments 3 and 5 were obtained from a soluble fraction. The full-length protein purified by Ni-nitrilotriacetic acid (NTA)-agarose migrated as a single band with a molecular weight somewhat higher than the predicted 24 kDa (Fig.6, A) . The protein yield was 2.072 mg/L as measured by Bradford assay (Bio-rad, Hercules, CA). Peptide fragments migrated at molecular weights higher than their predicted sizes on a 5~20% gradient SDS gel (Invitrogen). 24 (B) SDS-PAGE of full-length and peptide fragments. F, full-length; E1, 1~100 amino acid; E2, 34~77 amino acid; E3, 74~117; E4, 114~156; E5, 153~182.
IgE-binding reactivity of recombinant Bla g 4
The purified recombinant Bla g 4 was tested for its reactivity with IgE antibodies by ELISA in 32 sensitized sera to German cockroach extract. Among the 32 sera tested, 25% of the samples exhibited IgE reactivity to recombinant Bla g 4. Healthy human sera used as the negative control did not show any IgE reactivity. indicates the cut-off value. , Healthy control sera; , Sensitized sera to German cockroach extract (Uni-CAP > 0.7).
Determination of the IgE epitope
For the determination of IgE epitopes, Bla g 4-derived peptides were expressed as five overlapping recombinant peptides E1, E2, E3, E4 and E5. Four sera showing high level absorbance to recombinant Bla g 4 were selected for IgE epitope analysis. The IgE epitope study from Bla g 4-sensitized sera was performed by ELISA ( Fig. 8 ) and the results summarized in Table 3 . The results showed that IgE-binding sites were heterogeneously located among the different sera of the protein. IgE antibodies from patients 1, 2 and 4 were able to recognize fragments 2 and 4. However, fragments 1 and 3 were only recognized by the IgE antibodies of patients 2 and 1, respectively. All four sera recognized fragment 4. These results indicated that there were at least three IgE-binding antigenic determinants. showed only one amino acid substitution for each variant. 36 But, the frequency of Bla g 4 substitutions was remarkably high compared with other allergenic lipocalins. There was a high degree of coordinated sequence variation, especially for residues 29 to 39, 52 to 80 and 132 to 155, and to a lesser degree at 13, 92 and 111. Bla g 4 is known to be produced in the cockroach male reproductive organs and transferred to females during copulation. 30 The function of Bla g 4 in German cockroach is expected to play a role as a pheromone-binding protein. 23 The pheromone-binding protein in other insects was reported to show high levels of sequence variation. 37 The nature of these substitutions, thus, may appear to result from the protein's function in insects. This present data also indicates that the Bla g 4 variants could provide a good representation of divergence in the sequences.
Sequence comparison of lipocalin allergens reveals a family where homology is very low, with only residues G and W in the GXW triplet of the signature sequence located in the β-strand A being clearly conserved. 38 These result confirmed again that G and W were the conserved residues in the allergenic lipocalins.
The relationships between Bla g 4 variants were phylogenetically analyzed based on sequence similarity. Figure 4 shows the phylogenetic relationship between these variants. This analysis suggests that Bla g 4 has at least 5 isoforms in the related pair of the variants. The presence of Bla g 4 isoforms in cockroach could be demonstrated by two-dimensional IgE immunoblots of purified recombinant Bla g 4. The presence of multiple isoforms for other major allergens has also been reported. 39 The isoforms of Birch pollen allergen Bet v 1 and mite allergen Der p 2, which have 10 and 8 isoforms respectively, were reported to differ not only in the extent of IgE-binding activity but also in T cell activation. 39, 40 Moreover, isoforms of Der p 2 could induce different cytokine levels in allergic subjects. 39 It will be interesting to perform further studies to investigate the IgE binding to Bla g 4 isoforms.
The IgE-binding reactivity of recombinant Bla g 4 was assessed by ELISA, and 25% of German cockroach-sensitized Korean subjects were found to have positive IgE reactivity to recombinant Bla g 4. This prevalence was significantly lower than the 40~60% previously reported by Arruda et al. 13 Bla g 4 has been defined as the major allergen in allergic patients. but these results suggest a possibility of a minor allergen, a result supported by Satinover et al.
(prevalence 17.4%). 29 The discrepancies in the IgE-binding reactivity in the results obtained could be explained from two assumptions. One is to start with minor modifications of the complete molecule by amino acid substitution. If the modifications cause changes in the threedimensional structure, they could also be expected to affect the IgE binding. Intramolecular disulfide bridges are one characteristic of lipocalins. 41 Disruption of similar bridges in mite allergens has been shown to interfere with the IgE binding. [42] [43] [44] [45] Another factor is a glycosylation. 5 ). This finding suggests that glycosylation is not critical for allergenicity. However, it is obvious that the glycan moiety could affect the IgE binding of the allergen. 46 Deglycosylation of Can f 2 would reduce IgE binding but more studies are needed to confirm and explain these results. 47 Thus, it is quite possible that glycosylation may affect the binding of IgE.
To determine the IgE-binding epitope, it is necessary to assess the results of the immunological studies with reference to the molecular characteristics. Especially in the case of B-cell epitopes, three-dimensional structures are essential both for the localization of the IgE-binding regions and for the comparative structural analyses of lipocalin allergens. 38 This study is the first report of B-cell epitopes for Bla g 4. All the sera tested showed different patterns of IgE-reactivity (Table 3) . These results showed that although human IgE antibodies reacted with antigenic determinants distributed throughout the whole molecule, a major IgE-binding region was located at residues 118 to 152, close to the C-terminus of Bla g 4. The B-cell epitopes of Bos d 5 have been studied mostly using protein fragments, where residues 41 to 60, 102 to 124, and 149 to 162 were identified as the major epitopes, 48 a somewhat similar result in Bla g 4.
Therefore, comparison between other allergenic lipocalins needs to be done to determine whether all lipocalins are similar. Heterogeneity in IgE responses to Bla g 4 in individual patients was also observed, which correlated with the finding that the most allergens have multiple IgE-binding sites which is at least partly the result of the polyclonal nature of the immune response to protein allergens. [49] [50] [51] In summary, the predominant variants and allergenicity of the allergen in different regions can be different. We investigated the predominant variant and linear IgE binding epitope of Bla 
